Cellcolabs raised €10M in a funding round in Oct 2025. The company is based in Solna, Sweden. Investors in the round: Titian Capital. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
